Investor profile

Apposite Capital logo

Apposite Capital

PE

GBDEESFRNLSEITOtherHealthtechBio/PharmaDeep TechOther

See how your deck fits this investor's thesis, stage, and ticket size.

Analyse your fit

Investment thesis

Apposite Capital is a specialist pan-European healthcare private equity investor founded in 2006, focused exclusively on ambitious and growing European SME businesses across healthcare providers, digital health, medical products and devices, diagnostics, pharmaceuticals, pharmaceutical services, and life science tools. The firm acts as the first institutional capital to help healthcare SMEs scale and grow via management buyouts and buy-ins, growth and hybrid capital, retirement sales, and founder transitions, targeting companies with disruptive models that aim to improve or reduce the cost of care provision and which have the potential to become market leaders. Apposite's mission is to 'enable better healthcare for more people' by focusing on three core health impact objectives: improving quality, increasing access, and promoting innovation. The firm leverages deep thematic sector insights and an extensive pan-European network of over 500 operating partners and healthcare leaders to identify and support high-growth, high-impact opportunities, with portfolio companies achieving revenues and employment growth of over 20% per annum on average.

Notable quotes

The UK has an incredible depth of scientific research, entrepreneurial talent, and innovative companies, yet many businesses face a persistent gap in scale-up funding. This fund will bridge that gap, enabling high potential companies to accelerate their growth, commercialise transformative technologies, improve health outcomes and support economic growth.

Sam Gray · CB Insights / Apposite Healthcare Growth Fund I launch announcement · 2026-04-16

Apposite's mission is to build market leaders in healthcare by promoting excellence, innovation and good business practices. We seek to invest in businesses that are committed to making a positive impact by delivering high quality, efficient and cost-effective care solutions for the benefit of all – patients, service users and healthcare payers.

Sam Gray · Apposite Capital 2024 Impact Report · 2024-12-01

Had the pleasure of Apposite's Sam Gray being a member of the Wellpartner's Board of Directors for 5+ years. His help and guidance in turning the Company around and selling it to a strategic buyer was invaluable.

James Love · Apposite Capital website — WellPartner investment page

Team

Sam Gray

Managing Partner

HealthtechBio/PharmaDeep Tech

David Porter

Founding Partner

HealthtechBio/Pharma

Rory Pope

Partner

Healthtech

James Harper

Partner & CFO

Healthtech

Alex Cunynghame

Investment Director

HealthtechBio/Pharma

Lauren Miller

Investment Director

Healthtech

Recent investments

CompanyRoundSizeDate
EmblationMBO
NIMGeneticsBuy-in
HCMLBIMBO
Kelso PharmaGrowth
CrestOpticsGrowth
1MEDMBO
Mirada MedicalMBO
Swanton Care & CommunityBuyout
HabitusBIMBO
Imaging HoldingsMBI

Fit check

Is Apposite Capital a match for your startup?

Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.

Analyse your fit